Hyperfine (HYPR) Cash from Investing Activities (2021 - 2026)
Hyperfine's (HYPR) quarterly Cash from Investing Activities came in at -$242000.0 in Q1 2026, up 48.73% YoY from -$162712.3 in Q1 2025, and down 284.13% on a QoQ basis from -$63000.0 in Q4 2025.
Hyperfine (HYPR) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Cash from Investing Activities data on file, last reported at -$242000.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 48.73% year-over-year to -$242000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$955000.0 (down 34.51% YoY) and the FY2025 annual result came in at -$1.2 million, down 209.4% from the prior year.
- Cash from Investing Activities declined to -$242000.0 in Q1 2026, from -$63000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $54000.0 in Q2 2022 to a low of -$520000.0 in Q2 2025.
- A 5-year average of -$188176.5 and a median of -$159000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 110.69% — and 2025, when it tumbled 687.5%.
- Tracing HYPR's Cash from Investing Activities over 5 years: stood at -$158000.0 in 2022, then sank by 63.29% to -$258000.0 in 2023, then surged by 96.9% to -$8000.0 in 2024, then plunged by 687.5% to -$63000.0 in 2025, then slumped by 284.13% to -$242000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$242000.0 (Q1 2026), -$63000.0 (Q4 2025), and -$130000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Hyperfine | 90.12 Mn | 45.35 Mn | 1.98 Mn | -30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30,000.00 |
| Jun 30, 2026 | -30,000.00 |
| Mar 31, 2026 | -242,000.00 |
| Mar 31, 2026 | -242,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Mar 31, 2025 | -472,000.00 |
| Mar 31, 2025 | -472,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Jun 30, 2024 | -71,000.00 |
| Jun 30, 2024 | -71,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |